A prospective study on the risk-stratification for patients with non-sustained ventricular tachycardia using a novel algorithm

Circulation Journal

Volumn 71, Issue 7, 2007, Pages 1107-1114

  Ueno, Akira ^a   Kobayashi, Yoshinori ^a   Yodogawa, Kenji ^a   Miyauchi, Yasushi ^a   Yajima, Toshimi ^a   Nitta, Takashi ^a   Kato, Takao ^a   Takano, Teruo ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Algorithm; Electrophysiologic study; Non sustained ventricular tachycardia; Prophylactic ICD implantation

Indexed keywords

ADULT; AGED; ALGORITHM; ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; DEFIBRILLATOR; ELECTROCARDIOGRAM; FAMILY HISTORY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART STIMULATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PREVALENCE; PROSPECTIVE STUDY; RISK ASSESSMENT;

AGED; ALGORITHMS; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PATIENT SELECTION; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TACHYCARDIA, VENTRICULAR;

EID: 34347238167     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.1107     Document Type: Article

References (37)

1. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996; 335: 1933-1940.
2. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease: Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999; 341: 1882-1890.
3. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883.
4. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004; 350: 2151-2158.
5. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237.
6. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, et al. Canadian implantable defibrillator study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000; 101: 1297-1302.
7. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576-1583.
8. Camm AJ, Katritsis D. Risk stratification of patients with ventricular arrhythmias. In: Zipes DP, Jalife J, editors. Clinical electrophysiology: From cell to bedside, 3rd edn. Philadelphia: Saunders; 2000; 808-827.
9. Maggioni AP, Zuanetti G, Franzosi MG, Rovelli F, Santoro E, Staszewsky L, et al. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era: GISSI results. Circulation 1993; 87: 312-322.
10. Bigger JT, Fleiss JL, Rolnitzky LM. Prevalence, characteristics and significance of ventricular tachycardia detected by 24-hour continuous electrocardiographic recordings in the late hospital phase of acute myocardial infarction. Am J Cardiol 1986; 58: 1151-1160.
11. Doval HC, Nul DR, Grancelli HO, Varini SD, Soifer S, Corrado G, et al. Nonsustained ventricular tachycardia in severe heart failure: Independent marker of increased mortality due to sudden death: GESICA-GEMA Investigators. Circulation 1996; 94: 3198-3203.
12. Monserrat L, Elliott PM, Gimeno JR, Sharma S, Penas-Labo M, McKenna WJ. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: An independent marker of sudden death risk in young patients. J Am Coll Cardiol 2003; 42: 873-879.
13. Japanese Circulation Society. Guidelines for non-pharmacological therapy for cardiac arrhythmias. Jpn Circ J 2001; 65(Suppl V): 1127-1160.
14. Huikuri HV, Tapanainen JM, Lindgren K, Raatikainen P, Makikallio TH, Juhani Airaksinen KE, et al. Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era. J Am Coll Cardiol 2003; 42: 652-658.
15. Steinberg JS, Regan A, Sciacca RR, Bigger JT Jr, Fleiss JL. Predicting arrhythmic events after acute myocardial infarction using the signal-averaged electrocardiogram. Am J Cardiol 1992; 69: 13-21.
16. Grimm W, Christ M, Bach J, Muller HH, Maisch B. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: Results of the Marburg Cardiomyopathy Study. Circulation 2003; 108: 2883-2891.
17. Turitto G, Ahuja RK, Caref EB, El-Sherif N. Risk stratification for arrhythmic events in patients with nonischemic dilated cardiomyopathy and nonsustained ventricular tachycardia: Role of programmed ventricular stimulation and the signal-averaged electrocardiogram. J Am Coll Cardiol 1994; 24: 1523-1528.
18. Grimm W, Hoffmann J, Menz V, Luck K, Maisch B. Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia. J Am Coll Cardiol 1998; 32: 739-745.
19. Blilakis ES, Shen WK, Hammill SC, Hodge DO, Rea RF, Lxvoid NY, et al. Role of programmed ventricular stimulation and implantable cardioverter defibrillators in patients with idiopathic dilated cadiomyopathy and syncope. Pacing Clin Electrophysiol 2001; 24: 1623-1630.
20. Becker R, Haass M, Ick D, Krueger C, Bauer A, Senges-Becker JC, et al. Role of nonsustained ventricular tachycardia and programmed ventricular stimulation for risk stratification in patients with idiopathic dilated cardiomyopathy. Basic Res Cardiol 2003; 98: 259-266.
21. Strickberger SA, Hummel JD, Bartlett TG, Frumin HI, Schuger CD, Beau SL, et al. Amiodarone versus implantable cardioverter-defibrillator: Randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia: AMIOVIRT. J Am Coll Cardiol 2003; 41: 1707-1712.
22. Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, Deedwania PC, et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 1995; 333: 77-82.
23. McKenna WJ, Behr ER. Hypertrophic cardiomyopathy: Management, risk stratification, and prevention of sudden death. Heart 2002; 87: 169-176.
24. Limongelli G, Pacileo G, Cerrato F, Verrengia M, Di Simone A, Severino S, et al. Myocardial ultrasound tissue characterization in patients with hypertrophic cardiomyopathy: Noninvasive evidence of electrical and textural substrate for ventricular arrhythmias. J Am Soc Echocardiogr 2003; 16: 803-807.
25. Cripps TR, Counihan PJ, Frenneaux MP, Ward DE, Camm AJ, McKenna WJ. Signal-averaged electrocardiography in hypertrophic cardiomyopathy. J Am Coll Cardiol 1990; 15: 956-961.
26. Elliott PM, Poloniecki J, Dickie S, Monserrat L, Varnava A, Mahon NG, et al. Sudden death in hypertrophic cardiomyopathy: Identification of high risk patients. J Am Coll Cardiol 2000; 36: 2212-2218.
27. Zhu DW, Sun H, Hill R, Roberts R. The value of electrophysiology study and prophylactic implantation of cardioverter defibrillator in patients with hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 1998; 21: 299-302.
28. Fananapazir L, Chang AC, Epstein SE, McAreavey D. Prognostic determinants in hypertrophic cardiomyopathy: Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings. Circulation 1992; 86: 730-740.
29. Kennedy HL, Whitlock JA, Sprague MK, Kennedy LJ, Buckingham TA, Goldberg RJ. Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy. N Engl J Med 1985; 312: 193-197.
30. DiCarlo LA, Morady F, Schwartz AB, Shen EN, Baerman JM, Krol RB, et al. Clinical significance of ventricular fibrillation-flutter induced by ventricular programmed stimulation. Am Heart J 1985; 109: 959-964.
31. Buxton AE, Lee KL, Hafley GE, Wyse DG, Fisher JD, Lehmann MH, et al. Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: An analysis of patients enrolled in the multicenter unsustained tachycardia trial. Circulation 2002; 106: 2466-2472.
32. Turitto G, El-Sherif N. The signal averaged electrocardiogram and programmed stimulation in patients with complex ventricular arrhythmias. Pacing Clin Electrophysiol 1990; 13: 2156-2159.
33. Mancini DM, Wong KL, Simson MB. Prognostic value of an abnormal signal-averaged electrocardiogram in patients with nonischemic congestive cardiomyopathy. Circulation 1993; 87: 1083-1092.
34. Japanese Circulation Society. Guidelines for risks and prevention of sudden cardiac death. Circ J 2005; 69(Suppl IV): 1209-1252.
35. ACC/AHA/ESC. 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. J Am Coll Cardiol 2006; 48: e247-e346.
36. Tanno K, Miyoshi F, Watanabe N, Minoura Y, Kawamura M, Ryu S, et al. Are the MADIT II criteria for ICD implantation appropriate for Japanese patients? Circ J 2005; 69: 19-22.
37. Wolpert C, Kuschyk J, Aramin N, Spehl S, Streitner F, Suselbeck T, et al. Incidence and electrophysiological characteristics of spontaneous ventricular tachyarrhythmias in high risk coronary patients and prophylactic implantation of a defibrillator. Heart 2004; 90: 667-671.